Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Alternative splicing of the human glucocorticoid receptor (hGR) pre-mRNA generates two highly homologous isoforms, termed hGR alpha and hGR beta. hGR alpha is a ligand-activated transcription factor which, in the hormone-bound state, modulates the expression of glucocorticoid-responsive genes by binding to specific glucocorticoid response element (GRE) DNA sequences. In contrast, hGR beta does not bind glucocorticoids and is transcriptionally inactive. We demonstrate here that hGR beta is able to inhibit the effects of hormone-activated hGR alpha on a glucocorticoid-responsive reporter gene in a concentration-dependent manner. [3H]-Dexamethasone binding studies indicate that hGR beta does not alter the affinity of hGR alpha for its hormonal ligand. The presence of hGR beta in nuclear extracts and its ability to bind to a radiolabeled GRE oligonucleotide suggest that its inhibitory effect may be due to competition for GRE target sites. Reverse transcription-PCR analysis shows expression of hGR beta mRNA in multiple human tissues. These results indicate that hGR beta may be a physiologically and pathophysiologically relevant endogenous inhibitor of glucocorticoid action, which may participate in defining the sensitivity of target tissues to glucocorticoids. They also underline the importance of distinguishing between the two receptor isoforms in all future studies of hGR function and the need to revisit old data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These GR variants are derived from a single gene by alternative splicing and alternative translation initiation mechanisms.”
From Corticosteroids (2016) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Exon 2 forms the N-terminal domain of GR, exon 3–4 constitute the central DBD, while exons 5–9 code for the hinge and ligand-binding domain.”
From Corticosteroids (2016) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alternative splicing at exon 9 of primary GR transcript generates two highly homologous mRNA transcripts that results in the production of two GR isoforms termed GRα and GRβ (Fig.3A)43, 44.”
From Corticosteroids (2016) · cites this paper as [43]
In the citing paper
“The conventional belief that glucocorticoids act through a single GR protein has changed dramatically with the discovery of a diverse collection of receptor isoforms.”
From Corticosteroids (2016) · cites this paper as [43]
In the citing paper
“The GR protein is encoded by the Nr3c1 gene and consists of 9 exons; exon 1 forms the 5’-untranslated region, while exon 2–9 code for the GR protein.”
From Corticosteroids (2016) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439 · cited 1×
“receptor complex with other DNA elements and/or nuclear proteins then modulate the rate at which these genes are transcribed (6-8).”
BackgroundLipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179 · cited 1×
“48 h after transfection, cells were washed twice with PBS, and nuclear extracts were prepared essentially as described elsewhere (18).”
MethodThe Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Self-citationSTEROID RECEPTOR REGULATED TRANSCRIPTION OF SPECIFIC GENES AND GENE NETWORKS
Yamamoto, K. R. (1985) · Annual Review of Genetics · doi:10.1146/annurev.ge.19.120185.001233 · Cited by 1,872
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869 · cited 3×
“This difference renders hGRJ3 unable to bind glucocorticoid hormones and to be transcriptionally active (9, 11-14).”
BackgroundJonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566 · cited 1×
“Formation of non-GRE/DNA-binding complexes with the glucocorticoid receptor is believed to be the predominant mechanism by which previously described inhibitors of glucocorticoid action, such as c-jun (23-25), calreticulin (26, 27), and”
BackgroundYang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160 · cited 1×
“its transcriptionally active counterpart, and, therefore, fits the definition of a dominant negative inhibitor of hGRa (20).”
Background
Cited by
Items 101–200 of 640
Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects
Rohleder, N., Wolf, J. M., & Kirschbaum, C. (2003) · Stress · doi:10.1080/1025389031000153658 · Cited by 118
“Increased expression of GR-b relative to GR-a can dose-dependently decrease GC sensitivity by up to 90% (Bamberger et al., 1995).”
BackgroundDeRijk, R. H., van Leeuwen, N., Klok, M. D., & Zitman, F. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.012 · Cited by 117
“A glucocorticoid receptor-gene variant that has received a lot of attention, is the glucocorticoid receptor-β (Bamberger et al., 1995; DeRijk et al., 2001b).”
BackgroundZhang, X., Clark, A. F., & Yorio, T. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1279 · Cited by 118
Schaaf, M. J. M., & Cidlowski, J. A. (2002) · Steroids · doi:10.1016/s0039-128x(02)00015-6 · Cited by 130
Steroid and thyroid hormone receptors in mitochondria
Psarra, A. G., & Sekeris, C. E. (2008) · IUBMB Life · doi:10.1002/iub.37 · Cited by 115
“Two major glucocorticoid receptor isoforms, GR a and GR b , have been detected, products of alternative splicing ( 30, 31 ) (Fig.”
Newton, R., Leigh, R., & Giembycz, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.003 · Cited by 132
Pujols, L., Mullol, J., Pérez, M., Roca-Ferrer, J., Juan, M., Xaubet, A., Cidlowski, J. A., & Picado, C. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.1.4024 · Cited by 113
“hGR b does not show either ligand-binding activity (4, 5) or transactivation of target genes (5, 8). Using transfection studies, however, it has been reported that hGR b can inhibit hGR a -mediated stimulation of gene expression, acting as a dominant negative inhibitor of hGR a activity (5, 7 , 12).”
BackgroundTopical Glucocorticoids with Improved Risk-Benefit Ratio
Schäfer‐Korting, M., Schmid, M.-H., & Korting, H. C. (1996) · Drug Safety · doi:10.2165/00002018-199614060-00003 · Cited by 110
Poon, A. H., Eidelman, D. H., Martin, J. G., Laprise, C., & Hamid, Q. A. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.03983.x · Cited by 128
Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis
Ysrraelit, M. C., Gaitán, M. I., Lopez, A. S., & Correale, J. (2008) · Neurology · doi:10.1212/01.wnl.0000336918.32695.6b · Cited by 108
Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation
GOULDING, N. J., Euzger, H. S., Butt, S., & Perretti, M. (1998) · Inflammation Research · doi:10.1007/s000110050310 · Cited by 109
“The expression of the beta form of the receptor in many cells and tissues has led to speculation that it may function as an endogenous inhibitor of glucocorticoid action [9].”
BackgroundGlucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes
Kino, T., & Chrousos, G. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690437 · Cited by 109
“nucleus, where they interact with hormone-responsive elements and/or other transcription factors in the promoter regions of target genes (Bamberger et al. 1995).”
BackgroundSelf-citationMolecular mechanisms of corticosteroids in all_ergic diseases
Barnes, P. J. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.00001.x · Cited by 109
“A splice variant of GR, termed GR-b, has been identified that does not bind corticosteroids, but does bind to DNA, and theoretically may interfere with the action of corticosteroids by blocking GRE binding (2).”
Russcher, H., van Rossum, E. F. C., de Jong, F. H., Brinkmann, A. O., Lamberts, S. W. J., & Koper, J. W. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0467 · Cited by 110
Molecular mechanisms of immunomodulatory activity of glucocorticoids
Riccardi, C., Bruscoli, S., & Migliorati, G. (2002) · Pharmacological Research · doi:10.1006/phrs.2002.0969 · Cited by 122
Martinez, G. J., Appleton, M., Kipp, Z. A., Loria, A. S., Min, B., & Hinds, T. D. (2023) · Physiological Reviews · doi:10.1152/physrev.00021.2023 · Cited by 118
Kino, T., Stauber, R. H., Resau, J. H., Pavlakis, G. N., & Chrousos, G. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8017 · Cited by 105
“As hGR contains AF1 and can bind to GREs (6, 35), its unique LBD may somehow suppress AF1 as well as AF2.”
BackgroundSelf-citationColocalization of Glucocorticoid and Mineralocorticoid Receptors in Human Bone
Beavan, S., Horner, A., Bord, S., Ireland, D., & Compston, J. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1496 · Cited by 103
Maiyar, A. C., Phu, P. T., Huang, A. J. Y., & Firestone, G. L. (1997) · Molecular Endocrinology · doi:10.1210/me.11.3.312 · Cited by 107
Charmandari, E., Raji, A., Kino, T., Ichijo, T., Tiulpakov, A., Zachman, K., & Chrousos, G. P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1920 · Cited by 103
Self-citationPathophysiology of Glucocorticoid Signaling
Vitellius, G., Trabado, S., Bouligand, J., Delemer, B., & Lombès, M. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.001 · Cited by 116
Defining the role of glucocorticoids in inflammation
Ronchetti, S., Migliorati, G., Bruscoli, S., & Riccardi, C. (2018) · Clinical Science · doi:10.1042/cs20171505 · Cited by 109
Absence of Glucocorticoid Receptor-β in Mice
Otto, C., Reichardt, H. M., & Schütz, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26665 · Cited by 102
Corticosteroid Receptor Genetic Polymorphisms and Stress Responsivity
DeRijk, R. H., & de Kloet, E. R. (2005) · Endocrine · doi:10.1385/endo:28:3:263 · Cited by 115
The zebrafish as a model system for glucocorticoid receptor research
Schaaf, M. J. M., Chatzopoulou, A., & Spaink, H. P. (2009) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2008.12.014 · Cited by 121
Prakash, A., & Benfield, P. (1998) · Drugs · doi:10.2165/00003495-199855010-00009 · Cited by 108
“The β-type receptor has been suggested to inhibit the effects of the hormone-activated receptor, probably by competing for the glucocorticoid response elements.[14] A specific glucocorticoid receptor protein has been identified in the epidermis and dermis of both O HO H”
BackgroundLi, L.-B., Leung, D. Y. M., Martin, R. J., & Goleva, E. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0015oc · Cited by 99
Charmandari, E., Kino, T., Souvatzoglou, E., Vottero, A., Bhattacharyya, N., & Chrousos, G. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030450 · Cited by 99
Self-citationGlucocorticoid-resistant asthma: pathogenesis and clinical implications for management
Szefler, S. J., & Leung, D. Y. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10071640 · Cited by 98
“Another explanation that deserves further investigation is the potential induction of GCRβ, a result of alternative splicing of the GCR pre-messenger ribonucleic acid (mRNA), which acts as an endogenous inhibitor of GCR DNA binding [22].”
BackgroundPolymorphisms affecting gene regulation and mRNA processing: Broad implications for pharmacogenetics
JOHNSON, A., WANG, D., & SADEE, W. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.001 · Cited by 97
“Human glucocorticoid receptor beta (hGRh) acts as a dominant negative factor for the steroid-responsive human glucocorticoid receptor alpha (hGRa, Bamberger et al., 1995), and increased hGRh expression has been associated with steroid resistance in asthmatics (Hamid et al., 1999; Sousa et al.,…”
BackgroundExpression of Glucocorticoid Receptor Gene Isoforms in Corticotropin-Secreting Tumors1
Dahia, P. L. M., Honegger, J., Reincke, M., Jacobs, R. A., Mirtella, A., Fahlbusch, R., Besser, G. M., Chew, S. L., & Grossman, A. B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.4.3861 · Cited by 91
“In addition, GRb can repress the activity of GRa on glucocorticoid-responsive promoters (13, 15 ).”
Systemic Inflammation‐Associated Glucocorticoid Resistance and Outcome of ARDS
MEDURI, G. U., & YATES, C. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.004 · Cited by 96
Glucocorticoid receptors in human airways
Pujols, L., Mullol, J., Torrego, A., & Picado, C. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00635.x · Cited by 98
Reduced Glucocorticoid Receptor α Expression in Mood Disorder Patients and First-Degree Relatives
Matsubara, T., Funato, H., Kobayashi, A., Nobumoto, M., & Watanabe, Y. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.026 · Cited by 94
Beger, C., Gerdes, K., Lauten, M., Tissing, W. J. E., Fernandez‐Munoz, I., Schrappe, M., & Welte, K. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04426.x · Cited by 91
“…alpha isoform is responsible for GC-mediated transcriptional activation, while in the other isoforms either the hormone binding domain (hGR-beta, hGR-P) or the DNA binding domain (hGR-A, hGR-gamma) is disrupted (Hollenberg et al, 1985; Moalli et al, 1993; Bamberger et al, 1995; Rivers et al, 1999).”
BackgroundMethodAsthma phenotypes and endotypes
Lin, T.-Y., Poon, A. H., & Hamid, Q. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835b10ec · Cited by 93
Importin 13 Regulates Nuclear Import of the Glucocorticoid Receptor in Airway Epithelial Cells
Tao, T., Lan, J., Lukacs, G. L., Haché, R. J. G., & Kaplan, F. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0073oc · Cited by 90
“Human GR is believed to function as a dominant negative inhibitor of hGR ( 7 ).”
BackgroundMultilevel Interactions of Stress and Circadian System: Implications for Traumatic Stress
Agorastos, A., Nicolaides, N. C., Bozikas, V. P., Chrousos, G. P., & Pervanidou, P. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.01003 · Cited by 88
“, endothelial cells), acts mainly as negative regulator of hGRa transcriptional activity (61, 62).”
BackgroundSelf-citationMolecular Basis of Allergic Diseases
Leung, D. Y. M. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2682 · Cited by 99
Shintani, N., & Hunziker, E. B. (2011) · European Cells and Materials · doi:10.22203/ecm.v022a23 · Cited by 104
Nehmé, A., & Edelman, J. L. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0273 · Cited by 110
Glucocorticoid resistance as a major drive in sepsis pathology
Dendoncker, K., & Libert, C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.002 · Cited by 85
Glucocorticoids in the treatment of severe sepsis and septic shock
Annane, D. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000176691.95562.43 · Cited by 84
“The latter does not bind glucocorticoids and inhibits glucocorticoids receptor-a (GRa) activity, possibly through formation of antagonistic GRa/GRb heterodimers [ 6 ].”
BackgroundRestructuring the neuronal stress response with anti-glucocorticoid gene delivery
Kaufer, D., Ogle, W. O., Pincus, Z., Clark, K., Nicholas, A. C., Dinkel, K., Dumas, T. C., Ferguson, D., Lee, A. L., Winters, M. A., et al. (2004) · Nature Neuroscience · doi:10.1038/nn1296 · Cited by 87
Kelly, A., Bowen, H., Jee, Y.-K., Mahfiche, N., Soh, C., Lee, T., Hawrylowicz, C., & Lavender, P. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.010 · Cited by 83
Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis
van den Akker, E. L. T., Koper, J. W., Joosten, K., de Jong, F. H., Hazelzet, J. A., Lamberts, S. W. J., & Hokken-Koelega, A. C. S. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1468-6 · Cited by 81
“Three different 30-splice variants of the glucocorticoid receptor have been reported: GR-a, the most abundant, binds ligand and is functionally active; GR-P is thought to enhance the function of GR-a [15]; and GR-b is a dominant negative inhibitor of GR-a action [9, 16].”
BackgroundNontranscriptional actions of the glucocorticoid receptor
Limbourg, F. P., & Liao, J. K. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0418-y · Cited by 92
“Alternative mRNA splicing results in a second GR isoform, GRβ, that is defective in steroid binding and acts as a dominant negative inhibitor of GRα in vitro [3, 27, 28].”
BackgroundQuantitative analysis for human glucocorticoid receptor α/β mRNA in IBD
Orii, F., Ashida, T., Nomura, M., Maemoto, A., Fujiki, T., Ayabe, T., Imai, S., Saitoh, Y., & Kohgo, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02030-2 · Cited by 80
Brogan, I. J., Murray, I. A., Cerillo, G., Needham, M., White, A. E., & Davis, J. R. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00156-2 · Cited by 97
Diabetes Mellitus Secondary to Cushing’s Disease
Barbot, M., Ceccato, F., & Scaroni, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00284 · Cited by 75
“The A3669G polymorphism has been found to play a protective role in CD (24) by producing glucocorticoid resistance that increases the expression and stabilization of the dominant-negative GR-β splice variant (24, 25).”
BackgroundGlucocorticoid Receptor and Ubiquitin Expression after Repeated Eccentric Exercise
WILLOUGHBY, D. S., TAYLOR, M., & TAYLOR, L. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000099100.83796.77 · Cited by 78
Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis
Gu, G., Hentunen, T. A., Nars, M., Härkönen, P. L., & Väänänen, H. K. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1893-0 · Cited by 83
Different Skin Thinning Potential of Equipotent Medium-Strength Glucocorticoids
Körting, H. C., Unholzer, A., Schäfer‐Korting, M., Tausch, I., Gassmueller, J., & Nietsch, K.-H. (2002) · Skin Pharmacology and Physiology · doi:10.1159/000049394 · Cited by 77
Sionov, R. V., Spokoini, R., Kfir‐Erenfeld, S., Cohen, O., & Yefenof, E. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00406-5 · Cited by 88
“GR may, under certain circumstances, have a dominant negative effect on GR transactivation activity (Bamberger et al., 1995; Oakley et al., 1996, 1999; Yudt et al., 2003).”
BackgroundDeterminants of Specificity of Transactivation by the Mineralocorticoid or Glucocorticoid Receptor*
Lim-Tio, S. S., Keightley, M.-C., & Fuller, P. J. (1997) · Endocrinology · doi:10.1210/endo.138.6.5214 · Cited by 70
Alpha and beta glucocorticoid receptors: Relevance in airway diseases
Pujols, L., Mullol, J., & Picado, C. (2007) · Current Allergy and Asthma Reports · doi:10.1007/s11882-007-0005-3 · Cited by 75
Glucocorticoid and thyroid hormone receptors in mitochondria of animal cells
Scheller, K., Seibel, P., & Sekerist, C. E. (2003) · International review of cytology · doi:10.1016/s0074-7696(02)22011-2 · Cited by 73
Zhang, X., Clark, A. F., & Yorio, T. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0571 · Cited by 71
Guerrero, J., Gatica, H. A., Rodríguez, M., Estay, R., & Goecke, I. A. (2013) · Critical Care · doi:10.1186/cc12774 · Cited by 71
“The most studied are GR alpha (GRa), the classical receptor that mediates GC actions, and GR beta (GRb), which can act as a dominant negative [34-37].”
BackgroundSex Hormones and Lung Inflammation
Reyes-García, J., Montaño, L. M., Carbajal-García, A., & Wang, Y.-X. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-68748-9_15 · Cited by 65
Atopic dermatitis and the immune system: The role of superantigens and bacteria
Leung, D. Y. M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117024 · Cited by 84
Experimental and Clinical Studies
Sarkar, N. (2005) · Cited by 70
Glucocorticoid resistance syndrome: a diagnostic and therapeutic approach
van Rossum, E. F. C., & Lamberts, S. W. J. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.09.005 · Cited by 78
Syed, A. A., Irving, J. A. E., Redfern, C. P. F., Hall, A. G., Unwin, N. C., White, M., Bhopal, R. S., & Weaver, J. U. (2006) · Obesity · doi:10.1038/oby.2006.86 · Cited by 70
“Any reduction in GR /GR ratio is likely to result in decreased GR -induced transactivation on a GRE-driven promoter (1,2) and relative GC insensitivity.”
BackgroundSensitivity to Glucocorticoids Is Decreased in Relapsing Remitting Multiple Sclerosis
van Winsen, L. M. L., Muris, D. F. R., Polman, C. H., Dijkstra, C. D., van den Berg, T. K., & Uitdehaag, B. M. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0306 · Cited by 67
Structure and Function of the Glucocorticoid Receptor Ligand Binding Domain
Bledsoe, R. K., Stewart, E. L., & Pearce, K. H. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)68002-2 · Cited by 85
Effects of Glucocorticoids on Apoptosis and Clearance of Apoptotic Cells
McColl, A., Michlewska, S., Dransfield, I., & Rossi, A. G. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.224 · Cited by 79
“GCRβ has been suggested to interfere with GCRα function[21,22].”
BackgroundTorpy, D. J., & Chrousos, G. P. (1996) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(96)80014-8 · Cited by 69
Self-citationGlucocorticoid Receptor β: View I
Vottero, A., & Chrousos, G. P. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00179-4 · Cited by 76
Self-citationSinclair, D., Webster, M. J., Wong, J., & Weickert, C. S. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.28 · Cited by 66
The glucocorticoid receptor signalling in breast cancer
Moutsatsou, P., & Papavassiliou, A. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00177.x · Cited by 65
Hauk, P. J., Goleva, E., Strickland, I., Vottero, A., Chrousos, G. P., Kisich, K. O., & Leung, D. Y. M. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.4861 · Cited by 66
Self-citationTranscriptional and Metabolic Effects of Glucocorticoid Receptor α and β Signaling in Zebrafish
Chatzopoulou, A., Roy, U., Meijer, A. H., Alia, A., Spaink, H. P., & Schaaf, M. J. M. (2015) · Endocrinology · doi:10.1210/en.2014-1941 · Cited by 68
Psarra, A. G., Solakidi, S., Trougakos, I. P., Margaritis, L. H., Spyrou, G., & Sekeris, C. E. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.06.015 · Cited by 70
Prednicarbate Biotransformation in Human Foreskin Keratinocytes and Fibroblasts
Gysler, A., Lange, K., Körting, H. C., & Schäfer‐Korting, M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012162708675 · Cited by 65
Pedersen, K. B., & Vedeckis, W. V. (2003) · Biochemistry · doi:10.1021/bi034651u · Cited by 64
Mao, W., Tovar-Vidales, T., Yorio, T., Wordinger, R. J., & Clark, A. F. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8133 · Cited by 64
Usui, T., Saitoh, Y., & Komada, F. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.510 · Cited by 66
Lepelletier, Y., Zollinger, R., Ghirelli, C., Raynaud, F., Hadj-Slimane, R., Cappuccio, A., Hermine, O., Liu, Y.-J., & Soumelis, V. (2010) · Blood · doi:10.1182/blood-2010-05-282913 · Cited by 63
Fenech, A. G., & Hall, I. P. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01509.x · Cited by 74
“The early evidence to support this comes both from clinical observations [92] as well as from in vitro overexpression experiments in cell line models [93, 94], but the mechanisms for this action are still widely debated today.”
Bamberger, C. M., Wald, M., Bamberger, A., & Schulte, H. M. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00115-9 · Cited by 68
Self-citationChrousos syndrome: from molecular pathogenesis to therapeutic management
Nicolaides, N. C., & Charmandari, E. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12426 · Cited by 67
Glucocorticoid Receptor Signaling in Diabetes
Kokkinopoulou, I., Diakoumi, A., & Moutsatsou, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011173 · Cited by 70
“GRβ acts as a natural negative inhibitor of the GRα isoform [53].”
BackgroundDysfunction of the Hypothalamic-Pituitary-Adrenal axis in HIV infection and disease
Zapanti, E. D., Terzidis, K., & Chrousos, G. P. (2008) · HORMONES · doi:10.14310/horm.2002.1200 · Cited by 59
“Thus, the increased intracellular proportion of GRβ isoform leads to a decreased glucocorticoid effect.(29,30)”
BackgroundSelf-citationDeRijk, R. H., Eskandari, F., & Sternberg, E. M. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.009 · Cited by 64
“An alternative splicing product of the GR-gene, the GRh, has been characterized as a natural antagonist of the classic GR, GRa, which could, when present in excess, induce corticosteroid resistance (Bamberger et al., 1995).”
BackgroundDecreased Steroid Responsiveness at Night in Nocturnal Asthma
Kraft, M., Hamid, Q., Chrousos, G. P., Martin, R. J., & Leung, D. Y. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2002058 · Cited by 65
Self-citationGougat‐Barbera, C., Jaffuel, D., Gagliardo, R. P., Henriquet, C., Bousquet, J. J., Demoly, P. M., & Mathieu, M. N. (2001) · Journal of Molecular Medicine · doi:10.1007/s00109-001-0302-6 · Cited by 65
“GRβ may act as a dominant negative inhibitor of GRα -mediated transactivation [ 16 , 17].”
BackgroundAltered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients
Spiliotaki, M., Salpeas, V., Malitas, P., Alevizos, V., & Moutsatsou, P. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.02.006 · Cited by 58
Witchel, S. F., & DeFranco, D. B. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0323 · Cited by 58
Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones
Pera, T., & Penn, R. B. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.002 · Cited by 58
Koga, Y., Matsuzaki, A., Suminoe, A., Hattori, H., Kanemitsu, S., & Hara, T. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20308 · Cited by 58
“Consequently, GRbmay have a dominant negative effect on GRa [13,22].”
BackgroundMechanisms of Glucocorticoid‐Resistant Asthmaa
LEUNG, D. Y. M., de CASTRO, M., SZEFLER, S. J., & CHROUSOS, G. P. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09612.x · Cited by 61
Self-citationGlucocorticoids Enhance CD163 Expression in Placental Hofbauer Cells
Tang, Z., Niven‐Fairchild, T., Tadesse, S., Norwitz, E. R., Buhimschi, C. S., Buhimschi, I. A., & Guller, S. M. (2012) · Endocrinology · doi:10.1210/en.2012-1575 · Cited by 64
Sinclair, D., Tsai, S.-Y., Woon, H. G., & Weickert, C. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.160 · Cited by 68
“However, it is not known whether other human GR isoforms such as GRb, GR-‘A’ (D5–7), GR-P, and GRg (Bamberger et al, 1995; Moalli et al, 1993; Rivers et al, 1999) are expressed in the prefrontal cortex.”
BackgroundAssociations between promoter usage and alternative splicing of the glucocorticoid receptor gene
Russcher, H., Dalm, V. A. S. H., de Jong, F. H., Brinkmann, A. O., Hofland, L. J., Lamberts, S. W. J., & Koper, J. W. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02117 · Cited by 56
“This GR-b protein is not able to bind ligand and is reported to be a dominantnegative inhibitor of GR-a action (Bamberger et al. 1995, Oakley et al. 1996).”
BackgroundGlucocorticoids for Human Skin: New Aspects of the Mechanism of Action
Schäfer-Korting, M., Kleuser, B., Ahmed, M., Höltje, H.-D., & Korting, H. C. (2005) · Skin Pharmacology and Physiology · doi:10.1159/000084907 · Cited by 56
“Both isoforms are identical until amino acid 727, then 15 different residues follow in hGRβ. Due to the truncated C-terminal domain, hGRβ does not bind ligands any more and is transcriptionally inactive itself. Early investigations suggested a negative effect of hGRβ on hGRα effects [”
BackgroundXenobiotic receptors in mediating the effect of sepsis on drug metabolism
Lv, C., & Huang, L. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.003 · Cited by 62
Yan, Y., Dong, J., Liu, Y.-Q., Zhang, J., Song, M., He, Y. L., & Wang, W. (2014) · Stress · doi:10.3109/10253890.2014.999233 · Cited by 64
“GRa modulates the expression of glucocorticoid (GC)-responsive genes by binding to specific GC-response elements, whereas GRb does not bind GCs and is transcriptionally inactive (Bamberger et al., 1995; Oakley et al., 1999).”
Backgroundde Lange, P., Koper, J. W., Brinkmann, A. O., Jong, F. H. D., & Lamberts, S. W. J. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00072-6 · Cited by 71
Primary Generalized Glucocorticoid Resistance and Hypersensitivity Syndromes: A 2021 Update
Nicolaides, N. C., & Charmandari, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910839 · Cited by 58
Metadata
- Authors
- Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P.
- Affiliations
- National Institutes of Health (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1995-06-01
- Volume
- 95
- Issue
- 6
- Pages
- 2435-2441
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC295915
- OpenAlex
- W1974791065
- Cited by
- 642
- References
- 41
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 9 · 2023: 13 · 2022: 6 · 2021: 13 · 2020: 7 · 2019: 25 · 2018: 21 · 2017: 18 · 2016: 23 · 2015: 21 · 2014: 15 · 2013: 16 · 2012: 18
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoid receptor beta, glucocorticoid receptor alpha, alternative splicing, receptor isoforms, glucocorticoid response element, transcriptional repression, dexamethasone binding, glucocorticoid sensitivity
- MeSH terms
- Animals, Base Sequence, Cells, Cultured, Chlorocebus aethiops, Dexamethasone, DNA-Binding Proteins, Glucocorticoids, Humans, Molecular Sequence Data, Receptors, Glucocorticoid, Recombinant Proteins, Regulatory Sequences, Nucleic Acid, RNA, Messenger, Transcription, Genetic, Gene Expression, Alternative Splicing, DNA Primers, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.